Keyword: Genzyme

News

Sanofi Sticks to $69 per Share Genzyme Offer

13.09.2010 - French drugmaker Sanofi-Aventis poured cold water on a report it had raised its offer for U.S. biotechnology company Genzyme, saying it was sticking to its bid of $18.5 billion or...

News

Genzyme Begins Layoffs to Cut Costs

13.09.2010 - U.S. biotech company Genzyme has begun laying off an unspecified number of employees, a move it said was unrelated to Sanofi-Aventis' takeover bid. The company did not reveal the...

News

Sanofi has $10 Billion in Loans for Genzyme Bid

13.09.2010 - French drugmaker Sanofi-Aventis has put together about $10 billion in loans for its $18.5 billion bid for U.S. biotech company Genzyme, Bloomberg reported on Friday, citing unnamed...

News

Glaxosmithkline Head Says No Plan to Bid for Genzyme

07.09.2010 - Glaxosmithkline will not step in as a rival bidder for U.S. biotech Genzyme and take on Sanofi-Aventis, the British drugmaker's head of research and development told a French...

News

Sanofi-Aventis Ready to Raise Bid if Genzyme Talks

06.09.2010 - French drugmaker Sanofi-Aventis would be prepared to moderately raise its $69 per share offer for Genzyme if the U.S. biotech agreed to negotiate, Dow Jones reported, citing a...

News

Genzyme's Hand Strengthening vs Sanofi

02.09.2010 - U.S. biotech Genzyme, which has rejected an $18.5 billion offer from French drugmaker Sanofi-Aventis, appears to hold the upper hand in the takeover struggle, according to Geoffrey...

News

Total Hopes to Sell Lindsey Refinery by Year-end

02.09.2010 - French oil company Total has received offers for its UK Lindsey refinery and hopes to sell it by the end of the year, Chief Executive Officer Christophe de Margerie, said on...

News

Genzyme Rejects Sanofi Offer, Long Battle Looms

31.08.2010 - U.S. biotech company Genzyme rejected an $18.5 billion buyout offer from French drugmaker Sanofi-Aventis on Monday, setting the stage for a protracted and potentially hostile...